Alphyn Reports: FDA Clears Breakthrough Zabalafin Hydrogel For Atopic Dermatitis Treatment - Medical Device News Magazine

Medical Device News Magazine

Factuality

Ownership

Alphyn Reports: FDA Clears Breakthrough Zabalafin Hydrogel For Atopic Dermatitis Treatment - Medical Device News Magazine

"Zabalafin Hydrogel is on the cutting edge of an evolution in AD therapeutics to treat directly for the first time all aspects of the disease simultaneously. We believe it will be the compelling therapeutic choice to treat AD, offering excellent patient tolerability for worry free, long-term and continuous use, and comprehensive treatment for itch, inflammation, and managing the bacterial microbiome imbalance on the skin that exacerbates the dis…